Journal article
Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy
- Abstract:
-
BACKGROUND: Enhancer of zeste 2 (EZH2) promotes prostate cancer progression. We hypothesized that increased EZH2 expression is associated with postradiotherapy metastatic disease recurrence, and may promote radioresistance. METHODS: EZH2 expression was investigated using immunohistochemistry in diagnostic prostate biopsies of 113 prostate cancer patients treated with radiotherapy with curative intent. Associations between EZH2 expression in malignant and benign tissue in prostate biopsy cores...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Bibliographic Details
- Publisher:
- Wiley Publisher's website
- Journal:
- Prostate Journal website
- Volume:
- 79
- Issue:
- 10
- Pages:
- 1079-1089
- Publication date:
- 2019-05-18
- Acceptance date:
- 2019-04-12
- DOI:
- EISSN:
-
1097-0045
- ISSN:
-
0270-4137
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:999523
- UUID:
-
uuid:3c8bf8c0-8f96-4b33-b2c5-c0ad1e706ccd
- Local pid:
- pubs:999523
- Source identifiers:
-
999523
- Deposit date:
- 2019-05-20
Terms of use
- Copyright holder:
- Wu et al
- Copyright date:
- 2019
- Notes:
- © 2019 The Authors. The Prostate Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record